Vyxeos
Vyxeos ingredients
| Active ingredient | Strength |
|---|---|
| Cytarabine | 100 mg/20mL |
| Daunorubicin | 44 mg/20mL |
What Vyxeos is used for
The FDA lists the approved uses on the official label (below). In the EU, daunorubicin;cytarabine is approved as Vyxeos liposomal (previously Vyxeos) for:
Vyxeos liposomal is indicated for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Vyxeos
- Generic name
- (daunorubicin and cytarabine) liposome
- Made by
- Jazz Pharmaceuticals, Inc.
- Forms
- Injection, Powder, Lyophilized, For Suspension
- Given
- Intravenous
- Drug class
- Anthracycline Topoisomerase Inhibitor, Nucleoside Metabolic Inhibitor
- FDA approval
- New drug application (NDA) NDA209401
- On the US market since
- 2017
Official information
- Vyxeos prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for (daunorubicin and cytarabine) liposome)
In India
- Cytarabine: 36 brands in India
- Daunorubicin: 5 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Vyxeos?
Vyxeos ((daunorubicin and cytarabine) liposome) is a cancer medicine made by Jazz Pharmaceuticals, Inc., approved by the US FDA.
What are the ingredients of Vyxeos?
Vyxeos contains Cytarabine (100 mg/20mL); Daunorubicin (44 mg/20mL).
Is Vyxeos approved in Europe?
The same active substance is approved in the EU as Vyxeos liposomal (previously Vyxeos).
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA